These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35928927)

  • 1. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer.
    Hao T; Yu H; Huang D; Liu Q
    Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration.
    Lu Y; Wang K; Peng Y; Zhang J; Ju Q; Xu Q; Ouyang M; He Z
    PeerJ; 2023; 11():e16334. PubMed ID: 38025742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
    Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
    J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).
    Chen Y; Fu H; Zhang Y; Chen P
    Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
    Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
    Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane and Ubiquitin-Like Domain-Containing 1 Promotes Glioma Growth and Indicates Unfavorable Prognosis.
    Liu Y; Cai C; Wu K; Hu L
    Int J Genomics; 2023; 2023():3318171. PubMed ID: 38148953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes.
    Liu M; Yuan T; Liu H; Chen P
    Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tmub1 negatively regulates liver regeneration via inhibiting STAT3 phosphorylation.
    Fu H; Dong R; Zhang Y; Xu J; Liu M; Chen P
    Cell Signal; 2019 Mar; 55():65-72. PubMed ID: 30610893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms.
    Fu H; Zhang Y; Chen J; Zhou B; Chen G; Chen P
    Mol Ther Oncolytics; 2020 Sep; 18():126-136. PubMed ID: 32671188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-27a/b Regulates Liver Regeneration by Posttranscriptional Modification of Tmub1.
    Lan X; Li G; Liu H; Fu H; Chen P; Liu M
    Dig Dis Sci; 2018 Sep; 63(9):2362-2372. PubMed ID: 29777440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes.
    Fu H; Xu J; Chen J; Li G; Zhao X; Chen P
    Mol Med Rep; 2018 Mar; 17(3):4337-4344. PubMed ID: 29344642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
    Lu C; Liao W; Huang Y; Huang Y; Luo Y
    BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
    Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
    Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
    [No Abstract]   [Full Text] [Related]  

  • 17. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
    Zhang J; Liu W; Feng S; Zhong B
    World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
    Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
    Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [METTL27 is a prognostic biomarker of colon cancer and associated with immune invasion].
    Wang K; Zhang J; Deng M; Ju Y; Ouyang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):486-497. PubMed ID: 35527484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.